Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

taVNS Treatment for Fibromyalgia

NCT: NCT04777500 · NOT_YET_RECRUITING

NCT IDNCT04777500
StatusNOT_YET_RECRUITING
Start Date2026-10-03
Completion2027-03

Brief Summary

In this research study we want to learn more about if transcutaneous electrical nerve stimulation (TENS), a safe electrical stimulation tool, can relieve Fibromyalgia pain. A total of 60 subjects with Fibromyalgia will be enrolled in this study at Massachusetts General Hospital, Charlestown Navy Yard campus.

Frequently Asked Questions

What is taVNS Treatment for Fibromyalgia?

taVNS Treatment for Fibromyalgia is a clinical trial registered under NCT04777500. Current status: NOT_YET_RECRUITING.

What is the status of NCT04777500?

The current status of NCT04777500 (taVNS Treatment for Fibromyalgia) is: NOT_YET_RECRUITING.

When did taVNS Treatment for Fibromyalgia start?

taVNS Treatment for Fibromyalgia started on 2026-10-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑